Streetbeat News

Products Services

MDAI

Spectral AI, Inc. (NASDAQ:MDAI) stock is trading higher after the company announced the enrollment of the first patient in a study to validate its DeepView AI technology for burn injuries. This study is the final clinical trial before seeking FDA marketing authorization for the burn indication in 2025. The company has been using $251 million of non-dilutive government funding since 2019 to validate DeepView for burn indication and is also advancing other clinical indications. The stock experienced heavy trading volume, with over 15.3 million shares traded compared to its 100-day average volume of just under 972,000 shares.

Portfolio Pulse from Erica Kollmann

January 12, 2024 | 3:43 pm

BFLY

Butterfly Network Inc (NYSE:BFLY) shares rose after announcing expectations to exceed FY23 revenue and adjusted EBITDA loss guidance, with anticipated revenues of at least $64 million. The company also received FDA clearance for its new handheld ultrasound system, Butterfly iQ3, set to launch in Q1 2024. The positive financial outlook and product advancement have led to a 7.34% increase in BFLY shares in premarket trading.

Portfolio Pulse from Lekha Gupta

January 12, 2024 | 3:32 pm

LKNCY

Guming Holdings Ltd., a Chinese tea shop chain, has applied for a Hong Kong IPO, aiming to expand its franchise network and compete in China's mid-priced tea market. With 9,001 outlets, mostly franchised, Guming's profits tripled in the first nine months of last year. The company's success is attributed to its franchise model, competitive pricing, and focus on second- and third-tier cities. Guming faces competition from Mixue Group and established brands like Nayuki and Heytea, which are also adjusting prices to capture market share. Luckin Coffee (OTC:LKNCY) is also mentioned as a competitor in the beverage market.

Portfolio Pulse from The Bamboo Works

January 12, 2024 | 3:28 pm

CVS

TGT

WBA

CVS Health Corp is closing some of its pharmacies within Target stores due to shifts in market dynamics, consumer behavior, and health needs. The closures will start in February and end by April. Prescriptions will be transferred to nearby CVS locations. This is part of a broader industry trend of cost-cutting by U.S. pharmacy chains. CVS acquired Target's pharmacies in 2015 and recently introduced CVS 'CostVantage' for transparent drug cost reimbursement. Blue Shield of California will stop using CVS Caremark for drug benefits administration, except for specialty drugs. CVS shares fell 3.45% to $76.21.

Portfolio Pulse from Vandana Singh

January 12, 2024 | 3:27 pm

AAPL

GOOGL

META

MSFT

NVDA

QQQ

SPY

TSLA

The Market Clubhouse Morning Memo provides daily trade strategies for SPY, QQQ, AAPL, MSFT, META, TSLA, GOOGL, and NVDA, based on a proprietary formula considering price, volume, and options flow. The memo outlines potential bullish and bearish price levels for each asset and advises traders to monitor these stocks closely for breakouts or reversals. The session is expected to be light on data, with attention on the premarket release of the PPI. The memo is part of the Market Clubhouse membership, which offers daily market analysis, a watch list, and live trading streams.

Portfolio Pulse from RIPS

January 12, 2024 | 3:22 pm

REGN

VTRS

Regeneron Pharmaceuticals Inc (NASDAQ:REGN) won a lawsuit against Viatris Inc (NASDAQ:VTRS) over its Eylea patent, which, along with strong Dupixent sales and potential in the COPD market, has led BMO Capital Markets analyst Brian Abrahams to upgrade REGN from Sector Perform to Outperform with a new price target of $1,076. Abrahams anticipates Dupixent sales to reach $14.0 billion in 2024, surpassing consensus estimates. The recent patent win for Eylea and promising oncology programs like linvo and fianlimab are also positive indicators for REGN's stock. Following the news, REGN shares rose by 1.50% to $929.68.

Portfolio Pulse from Priya Nigam

January 12, 2024 | 3:18 pm

COIN

MARA

MSTR

The launch of Bitcoin spot ETFs in the US is expected to impact traditional crypto stocks like Coinbase (COIN), Marathon Digital (MARA), and MicroStrategy (MSTR). While ETFs provide direct Bitcoin exposure, they may reduce investor interest in crypto equities. The upcoming Bitcoin halving event could further affect miner profitability. Despite potential challenges, some industry players remain positive about the market expansion due to ETFs. JPMorgan notes that mining stocks may face headwinds as they are currently trading at near all-time highs.

Portfolio Pulse from Murtuza Merchant

January 12, 2024 | 3:13 pm

RMD

The FDA has classified ResMed Ltd's (NYSE:RMD) recall of certain CPAP masks with magnets as a Class I recall, the most serious type. The magnets may interfere with certain medical devices, potentially causing serious harm or death. ResMed is updating labels to include more warnings and has recalled over 20 million devices in the U.S. since November 20, 2023. There have been six reported injuries but no deaths. RMD shares dropped 0.47% to $177.06.

Portfolio Pulse from Vandana Singh

January 12, 2024 | 3:07 pm

GEF

Greif, Inc. has entered into a pilot-project partnership with IonKraft to address recyclability and sustainability issues in plastic jerrycan packaging. The partnership focuses on developing a barrier solution to enhance the environmental friendliness of these containers.

Portfolio Pulse from Benzinga Newsdesk

January 12, 2024 | 3:02 pm

601899.SS

LUG.TO

Zijin Mining Group is investing $97 million in Solaris Resources to advance its Warintza copper project in Ecuador. Zijin will purchase 28.5 million shares at a 14% premium, becoming the second-largest shareholder with about 15% ownership. The investment will help Solaris leverage Zijin's expertise and financial capacity. Despite security concerns in Ecuador, mining operations continue with enhanced measures, and no foreign companies have left the country.

Portfolio Pulse from Stjepan Kalinic

January 12, 2024 | 2:59 pm